Skip to main content
Clinical Trials/JPRN-UMIN000013601
JPRN-UMIN000013601Completed未知

Safe and effective sedation in endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma: a randomized comparsion between propofol and midazolam. - Propofol vs midazolam for sedation in endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.

Department of Gastroenterology, Osaka City University Graduate School of Medicine0 sites132 target enrollmentStarted: April 3, 2014Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
132

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Severe disease in heart, lung, liver, or kidney. Allergic episode with propofol or midazolam. Women in pregnancy or breast-feeding Any other reasosn by which docter judged inappropriate case.

Investigators

Sponsor
Department of Gastroenterology, Osaka City University Graduate School of Medicine

Similar Trials

Safe and effective sedation in endoscopic... | Clinical Trial